Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

ICU TopicsHaematology / coagulation

ICU · Haematology / coagulation

Thrombocytopenia in the ICU — HIT, TTP/HUS, ITP & Septic

Also known as Thrombocytopenia · Heparin-induced thrombocytopenia · HIT · 4T score · Thrombotic thrombocytopenic purpura · TTP · Haemolytic uraemic syndrome · HUS · ADAMTS13 · Immune thrombocytopenia · ITP · Argatroban · Bivalirudin · Plasmapheresis · Caplacizumab

The ICU thrombocytopenia differential: the HIT (heparin-induced — the PF4-heparin antibodies; thrombocytopenia AND thrombosis; 4T score; STOP ALL HEPARIN; switch to argatroban or bivalirudin; NO platelets), the TTP (ADAMTS13 deficiency; MAHA plus neuro; plasmapheresis plus steroids plus caplacizumab; NO platelets), the HUS (Shiga toxin E coli; renal; eculizumab), the ITP (isolated; steroids or IVIG), the septic (the commonest — treat sepsis), the drug-induced, the DIC, the dilutional, the marrow failure. The key: HIT and TTP have thrombocytopenia with THROMBOSIS (paradoxical) — and NO platelets in either (worsens the microvascular thrombosis). The TTP and HUS have the MAHA (schistocytes, raised LDH, low haptoglobin). The 4T score for the HIT; the ADAMTS13 for the TTP; the plasmapheresis is the definitive for the TTP.

high26 referencesUpdated 26 July 202630 min readSource-verified · Oct 2026

Checked against its sources on 14 Oct 2026

Your progress

Saved on this device.

Target exams

CICMFFICMEDIC
On this page
Study tools

Your progress

Saved on this device.

Target exams

CICMFFICMEDIC

Overview & definition

Thrombocytopenia is common in ICU patients, and the two diagnoses that will hurt your patient if missed are HIT and TTP. Both present as thrombocytopenia with paradoxical thrombosis, and in both, platelet transfusion is contraindicated — it fuels the microvascular occlusion.[1]

Thrombocytopenia is a platelet count below the reference range; prophylactic transfusion thresholds run at 10 × 10⁹ cells/L for hypoproliferative patients and under 50 × 10⁹ for major elective nonneuraxial surgery. Sepsis is the commonest cause, but the count you must not dismiss is the one falling on day 8 of heparin or the one ringed by schistocytes.[1][23]

Frame every case through D-I-S-C — Destruction, Inadequate production, Sequestration, Consumption and dilution. The mantra: thrombocytopenia with thrombosis — HIT or TTP — and neither gets platelets.[1]

ICU Fellowship (CICM) Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the ICU Fellowship (CICM) fellowship library.

Sign in to continueSee pricing
References26ShowHide
  1. [1]Warkentin TE Heparin-induced thrombocytopenia: IgG-mediated platelet activation, platelet microparticle generation, and altered procoagulant/anticoagulant balance in the pathogenesis of thrombosis and venous limb gangrene complicating heparin-induced thrombocytopenia Transfus Med Rev, 1996.PMID 8899954
  2. [2]Warkentin TE Think of HIT Hematology Am Soc Hematol Educ Program, 2006.PMID 17124091
  3. [3]Cuker A Does my patient have HIT? There should be an app for that Blood, 2016.PMID 26847066
  4. [4]Cuker A, Arepally GM, Chong BH, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: heparin-induced thrombocytopenia Blood Adv, 2018.PMID 30482768
  5. [5]Lewis BE, Walenga JM Argatroban in HIT type II and acute coronary syndrome Pathophysiol Haemost Thromb, 2002.PMID 12811012
  6. [6]Nutescu EA, Wittkowsky AK Direct thrombin inhibitors for anticoagulation Ann Pharmacother, 2004.PMID 14742803
  7. [7]Smythe MA, Warkentin TE, Woodhouse AL, et al. Venous limb gangrene and fatal hemorrhage: adverse consequences of HIT overdiagnosis in a patient with antiphospholipid syndrome Am J Hematol, 2011.PMID 21264902
  8. [8]Linkins LA, Warkentin TE The approach to heparin-induced thrombocytopenia Semin Respir Crit Care Med, 2008.PMID 18302088
  9. [9]Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group N Engl J Med, 1991.PMID 2062330
  10. [10]Tsai HM Advances in the pathogenesis, diagnosis, and treatment of thrombotic thrombocytopenic purpura J Am Soc Nephrol, 2003.PMID 12660343
  11. [11]Scully M, Cataland SR, Peyvandi F, et al. Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic Purpura N Engl J Med, 2019.PMID 30625070
  12. [12]Peyvandi F, Scully M, Kremer Hovinga JA, et al. Caplacizumab for Acquired Thrombotic Thrombocytopenic Purpura N Engl J Med, 2016.PMID 26863353
  13. [13]Zheng XL, Vesely SK, Cataland SR, et al. ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpura J Thromb Haemost, 2020.PMID 32914582
  14. [14]Zheng XL, Vesely SK, Cataland SR, et al. ISTH guidelines for treatment of thrombotic thrombocytopenic purpura J Thromb Haemost, 2020.PMID 32914526
  15. [15]Walsh PR, Johnson S Eculizumab in the treatment of Shiga toxin haemolytic uraemic syndrome Pediatr Nephrol, 2019.PMID 30058046
  16. [16]Slichter SJ, Kaufman RM, Assmann SF, et al. Dose of prophylactic platelet transfusions and prevention of hemorrhage N Engl J Med, 2010.PMID 20164484
  17. [17]Stanworth SJ, Estcourt LJ, Powter G, et al. A no-prophylaxis platelet-transfusion strategy for hematologic cancers N Engl J Med, 2013.PMID 23656642
  18. [18]Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer T, Godeau B, Grainger J, Greer I, Hunt BJ, Imbach PA, Lyons G, McMillan R, Rodeghiero F, Sanz MA, Tarantino M, Watson S, Young J, Kuter DJ International consensus report on the investigation and management of primary immune thrombocytopenia Blood, 2010.PMID 19846889
  19. [19]Neunert C, Terrell DR, Arnold DM, et al. American Society of Hematology 2019 guidelines for immune thrombocytopenia Blood Adv, 2019.PMID 31794604
  20. [20]Pavord S, Scully M, Hunt BJ, Lester W; on behalf of the Expert Haematology Panel Clinical Features of Vaccine-Induced Immune Thrombocytopenia and Thrombosis N Engl J Med, 2021.PMID 34379914
  21. [21]Cuker A, Gimotty PA, Crowther MA, Warkentin TE Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis Blood, 2012.PMID 22990018
  22. [22]Bendapudi PK, Hurwitz S, Fry A, et al. Derivation and external validation of the PLASMIC score for rapid assessment of adults with thrombotic microangiopathies: a cohort study Lancet Haematol, 2017.PMID 28259520
  23. [23]Kaufman RM, Djulbegovic B, Gernsheimer T, et al. Platelet transfusion: a clinical practice guideline from the AABB Ann Intern Med, 2015.PMID 25383671
  24. [24]Warkentin TE Heparin-induced thrombocytopenia-associated thrombosis: from arterial to venous to venous limb gangrene J Thromb Haemost, 2018.PMID 30099843
  25. [25]Mashhadi MA, Kaykhaei MA, Sepehri Z, Miri-Moghaddam E Single course of high dose dexamethasone is more effective than conventional prednisolone therapy in the treatment of primary newly diagnosed immune thrombocytopenia Daru, 2012.PMID 23351609
  26. [26]Owczarzak L, Alrifai T, Jain S, Dehghan-Paz I Uncommon Presentation of Post-Transfusion Purpura in an Elderly Male: A Case Report and Unique Alloantibody Identification Am J Case Rep, 2024.PMID 38978279
ICU Fellowship (CICM) Pro

$29/ monthor $279 / year

The complete ICU Fellowship (CICM) library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousHemophagocytic Lymphohistiocytosis (HLH) and Macrophage Activation Syndrome (MAS) in the ICUhaematology-coagulationNextVTE Prophylaxis & Treatment — LMWH, IPC, Thrombolysis & the ICU DefaultHaematology / coagulation